濒危植物——长喙毛茛泽泻的雌雄配子体发育

长喙毛茛泽泻 Ranalisma rostratum stapf 小孢子母细胞的减数分裂过程为连续型,四分体为左右对称型。成熟花粉为三胞花粉。花药绒毡层为变形绒毡层。雌蕊由多数单室子房构成,每子房中含一具双珠被、薄珠心的倒生胚珠。胚囊发育为葱型。成熟胚囊中三个反足细胞退化;二个极核分别位于中央细胞的两端,其体积相差明显。这种极核分布可能与反足细胞过早退化有关。     

籼稻的抗冷性与亲本的关系

四个籼稻（Ｏｒｙｚａ ｓａｔｉｖａ Ｌ．）品种幼苗经１℃黑暗或光照２５０ μｍ ｏｌ·ｍ － ２·ｓ－ １处理后,抗冷的“桂山矮选３”比不抗冷的“青华６ 号”幼苗存活率高,其子代是以“桂山矮选３”为母本的比“青华６ 号”为母本的存活率较高。抽穗期剑叶经光照低温处理１２、２４ 和３６ ｈ 后,光合作用是“桂山矮选３”和以“桂山矮选３”为母本的子代比“青华６ 号”和以“青华６ 号”为母本的子代下降较少。呼吸作用是前者比后者在处理１２ ｈ 时有明显升高现象。荧光参数Ｆｖ／Ｆｏ和Ｆｖ／Ｆｍ比值在处理２４ ｈ 时前者比后者下降明显,但在常温下恢复则是前者比后者明显较快。自然低温（寒露风）对叶绿素荧光的影响亦有相似的规律。对水稻后代的抗冷性倾向于母本进行了讨论     

脱落酸对线粒体Na^＋—K^＋ATPase活性的影响

在提取大豆（Ｇｌｙｃｉｎｅ ｍ ａｘ）黄化子叶的线粒体时,于清洗和悬浮介质中加入ＡＢＡ,发现４０ μｍ ｏｌ／Ｌ（±） ＡＢＡ 对线粒体膜结合Ｎａ＋ －Ｋ＋ ＡＴＰａｓｅ 活性及线粒体吸氧速率有明显的促进作用。ＡＢＡ 可使１６℃与２７℃培养的大豆子叶线粒体膜结合Ｎａ＋ －Ｋ＋ ＡＴＰａｓｅ Ａｒｒｈｅｎｉｕｓ图的折点温度分别下降６．３℃和５．９℃,并将该酶的底物动力学曲线由正协同曲线转变为非协同曲线。表明ＡＢＡ 可降低线粒体的膜相变温度     

杨树新品种叶肉原生质体培养和植株再生

从１ 个月龄的ＮＬ－８０１０６ 杨（Ｐｏｐｕｌｕｓｄｅｌｔｏｉｄｅｓ×Ｐ． ｓｉｍ ｏｎｉｉ）无菌苗叶片分离得到大量原生质体,纯化后其原生质体产量为４×１０７／ｇ ｆｒ．ｗ ｔ． 纯化的原生质体在含２,４－Ｄ ２ ｍ ｇ／Ｌ、ＮＡＡ ０．５ ｍ ｇ／Ｌ和ＫＴ ０．５ ｍ ｇ／Ｌ的ＫＭ８ｐ 和ＭＳ培养基中进行高密度液体浅层培养,渗透势为０．４０ ｍ ｏｌ／Ｌ的ＫＭ８ｐ 培养基中原生质体分裂频率最高． 培养第５ 天观察到第一次细胞分裂,培养１０ ｄ 的分裂频率为４．５％ ,１２ 周内可形成大量的细胞团和小愈伤组织． ＮＬ－８０１０６杨叶肉原生质体在富含有机氮并以葡萄糖为碳源的培养基中具有较高的分裂频率和植板率．小愈伤组织在ｇｅｌｒｉｔｅ 固化的ＮＬＺ１ 培养基上增殖生长,３ 周后形成４—６ ｍ ｍ 结构紧密的鲜红色愈伤组织,转至ＮＬＦ分化培养基,分化成苗率为１００％ ． 待芽伸长到３ ｃｍ 时,从基部切下转至１／２ ＭＳ培养基上诱导生根,形成完整植株     

玉米根ABA结合蛋白的亚细胞定位及动力学性质

以玉米（Ｚｅａ ｍａｙｓＬ．）根或胚芽鞘为材料,经匀浆、分级离心得到胞质部分和膜部分（微粒体）,进一步用６．２％ （Ｗ／Ｗ ） Ｄｅｘｔｒａｎ Ｔ５００ 和ＰＥＧ ３３５０ 两相系统制备质膜,用１％ 和８％ （Ｗ ／Ｗ） Ｄｅｘｔｒａｎ Ｔ７０ 梯度离心制备液泡膜． 电镜鉴定及多种标志酶检测表明,制备获得了高纯度正向型质膜和富含液泡膜的组分,其它内膜的污染很少． 用微量放射配体结合（ＭＲＬＢ）实验证明,玉米根微粒体的ＡＢＡ专一性结合位点主要分布在液泡膜和质膜上,这两种膜组分与ＡＢＡ 的特异结合活性分别为２４８５．４ ｆｍ ｏｌ／ｍ ｇ ｐｒｏｔｅｉｎ 和１２５７．３ ｆｍ ｏｌ／ｍ ｇ ｐｒｏ－ｔｅｉｎ,玉米根段胞质部分结合活性最低（差一个数量级）．质膜上ＡＢＡ－ＢＰ与ＡＢＡ 的结合平衡解离常数（ＫＤ）为１．５７ ｎｍ ｏｌ／Ｌ．     

Melatonin administration prevents lipopolysaccharide-induced oxidative damage in phenobarbital-treated animals

The protective effect of melatonin on lipopolysaccharide (LPS)-induced oxidative damage in phenobarbital-treated rats was measured using the following parameters: changes in total glutathione (tGSH) concentration, levels of oxidized glutathione (GSSG), the activity of the antioxidant enzyme glutathione peroxidase (GSH-PX) in both brain and liver, and the content of cytochrome P450 reductase in liver. Melatonin was injected intraperitoneally (ip, 4mg/kg BW) every hour for 4 h after LPS administration; control animals received 4 injections of diluent. LPS was given (ip, 4 mg/kg) 6 h before the animals were killed. Prior to the LPS injection, animals were pretreated with phenobarbital (PB), a stimulator of cytochrome P450 reductase, at a dose 80 mg/kg BW ip for 3 consecutive days. One group of animals received LPS together with N^w-nitro-L-arginine methyl ester (L-NAME), a blocker of nitric oxide synthase (NOS) (for 4 days given in drinking water at a concentration of 50 mM). In liver, PB, in all groups, increased significantly both the concentration of tGSH and the activity of GSH-PX. When the animals were injected with LPS the levels of tGSH and GSSG were significantly higher compared with other groups while melatonin and L-NAME significantly enhanced tGSH when compared with that in the LPS-treated rats. Melatonin alone reduced GSSG levels and enhanced the activity of GSH-PX in LPS-treated animals. Additionally, LPS diminished the content of cytochrome P450 reductase with this effect being largely prevented by L-NAME administration. Melatonin did not change the content of P450 either in PB- or LPS-treated animals. In brain, melatonin and L-NAME increased both tGSH levels and the activity of GSH-PX in LPS-treated animals. The results suggest that melatonin protects against LPS-induced oxidative toxicity in PB-treated animals in both liver and brain, and the findings are consistent with previously published observations related to the antioxidant activity of the pineal hormone.     

Positive correlation between cellular glutathione and acquired cisplatin resistance in human ovarian cancer cells

While multiple changes are frequently found to be associated with cisplatin resistance in a variety of tumor cell lines, a cause-effect relationship of these alterations with the resistant phenotype has not been established. In order to identify the resistance-relevant determinants, a series of cisplatinresistant sublines with different degrees of resistance to cisplatin was developed in a human ovarian carcinoma cell line (O-129). Three derived resistant cell lines displayed 2.1-fold (O-129/DDP₄, low), 4.1-fold (O-129/DDP₈, moderate) and 6.3-fold (O-129/DDP₁₆, high) resistance, respectively, to cisplatin, compared with the sensitive parental line O-129. While the activity of poly(ADP-ribose) polymerase, an enzyme proposed to be involved in DNA repair, was elevated in all three resistant lines, a significant karyotypic change was observed only in the high-resistance line with the karyotype alteration from near diploidy to heteroploidy. The moderate (4.1-fold) and high (6.3-fold) DDP resistance was associated with a slow proliferation rate in drug-free medium, but cellular glutathione level was highly correlated with DDP sensitivity in all four cell lines. Taken together, the present studies establish that while many changes at cellular level can occur with development of cisplatin resistance, only elevation of intracellular glutathione concentration appears to be related to the resistance phenotype in these human ovarian cancer cells.Abbreviations DDP cisplatin - FBS fetal bovine serum - GSH glutathione - IC₅₀ drug concentration required to result in 50% growth inhibition - PARP poly(ADP-ribose) polymerase     

Characterization of a silencer element in the first exon of the human osteocalcin gene.

Osteocalcin, the major non-collagenous protein in bone, is transcribed in osteoblasts at the onset of extracellular matrix mineralization. In this study it was demonstrated that sequences located in the first exon of the human osteocalcin gene possess a differentiation-related osteocalcin silencer element (OSE). Osteocalcin was rendered transcribable in UMR-106 cells and proliferating normal osteoblasts after deletion of the -3 to +51 region. Site-specific mutagenesis of this region revealed that a 7 bp sequence (TGGCCCT) (+29 to +35) is critical for silencing function. Mobility shift assays demonstrated that a nuclear factor bound to the OSE. The OSE binding protein was present in proliferating normal pre-osteoblasts and in UMR-106 and ROS 17/2.8 osteosarcoma cells, but was absent from post-proliferative normal osteoblasts. The binding protein was inhibited by fragments containing the +29/+35 sequence, but not by other promoter fragments or by the consensus oligomers of unrelated nuclear factors AP-1 and Sp1. DNase 1 footprinting demonstrated that the OSE binding-protein protected the +17 to +36 portion of the first exon, consistent with the results of mapping studies and competitive mobility shift assays. It is hypothesized that this silencer is activated by complexing of the OSE binding protein to the OSE during the osteoblast proliferation stage and that the OSE binding protein is down-regulated at the onset of extracellular matrix mineralization.     

Cleavage site determinants in the mammalian polyadenylation signal.

Using a series of position and nucleotide variants of the SV40 late polyadenylation signal we have demonstrated that three sequence elements determine the precise site of 3-end cleavage in mammalian pre-mRNAs: an upstream AAUAAA element, a down-stream U-rich element consisting of five nucleotides, at least four of which are uridine, and a nucleotide preference at the site of cleavage in the order A > U > C >> G. Cleavage occurs no closer than 11 bases, but no further than 23 bases from the AAUAAA element. The downstream U-rich element is usually located 10-30 bases from the cleavage site. The relative position of the AAUAAA and the U-rich elements define the approximate region within a 13 base domain in which cleavage will occur. The exact position of cleavage is then determined by the local nucleotide sequence in the order of preference noted above. This model accounts for nearly three quarters of polyadenylation signals surveyed and is consistent with previous experimental observations.